State-of-the-art AI programs can support the development of drugs by predicting the interaction of proteins with small molecules. However, researchers at the University of Basel show that these programs only memorize patterns instead of understanding physical relationships. They often fail with new proteins that would be particularly interesting for innovative drugs. Read more